Dear colleagues,

The following Special Issue will be published in Pharmaceuticals
(http://www.mdpi.com/journal/pharmaceuticals/, ISSN 1424-8247), and is
now open to receive submissions of full research papers and
comprehensive review articles for peer-review and possible publication:

Special Issue: Cell-penetrating Peptides
Website: http://www.mdpi.com/si/pharmaceuticals/peptides/
Guest Editor: Prof. Dr. Vladimir P. Torchilin
Deadline for manuscript submissions: 30 September 2012

You may send your manuscript now or up until the deadline.
Submitted papers should not have been published previously, nor be under
consideration for publication elsewhere. We also encourage authors to send
us their tentative title and short abstract by e-mail for approval to the
Editorial Office at pharmaceuticals@mdpi.com.

This Special Issue will be fully open access. Open access (unlimited and
free access by readers) increases publicity and promotes more frequent
citations as indicated by several studies. Open access is supported by the
authors and their institutes. More information is available at
http://www.mdpi.com/about/openaccess/.

Article Processing Charges are 500 CHF per accepted article.
An additional fee of 250 CHF may apply if English editing or extensive
revisions must be undertaken by the Editorial Office. More information can
be found at http://www.mdpi.com/about/apc/.

Pharmaceuticals (ISSN 1424-8247) is an international, peer-reviewed
open access journal on pharmaceutical sciences, including molecular
medicine. Pharmaceuticals is published by MDPI online monthly.

Please visit the Instructions for Authors website before submitting a paper
at http://www.mdpi.com/journal/pharmaceuticals/instructions/. Manuscripts
should be submitted through the online manuscript submission and editorial
system at http://www.mdpi.com/user/manuscripts/upload/.

MDPI publishes several peer-reviewed, open access journals listed at
http://www.mdpi.com/. The Editorial Board members, including several
Nobel Laureates (http://www.mdpi.com/about/nobelists/), are all leading
active scholars. All MDPI journals maintain rapid, yet rigorous, peer-
review, manuscript handling and editorial processes. MDPI journals have
increased their impact factors, see "2010 Newly Released Impact Factors",
http://www.mdpi.com/about/announcements/121/.

In case of questions, please contact the Editorial Office at:
pharmaceuticals@mdpi.com

We are looking forward to hearing from you.

Kind regards,
MDPI AG

On behalf of the Guest Editor

Prof. Dr. Vladimir P. Torchilin
Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University, Mugar Hall, Room 312
360 Huntington Avenue
Boston, MA 02115
USA
Website: http://www.northeastern.edu/bouve/faculty/torchilin_v.html
E-Mail: v.torchilin@neu.edu

--
Editor-in-Chief of Pharmaceuticals
Dr. Derek J. McPhee
E-Mail: mcphee@mdpi.com

--
MDPI AG
Kandererstrasse 25
CH-4057 Basel, Switzerland
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
E-Mail: pharmaceuticals@mdpi.com
http://www.mdpi.com/